首页> 外文期刊>Биохимия >Inducible nitric oxide synthase in the liver: regulation and functions
【24h】

Inducible nitric oxide synthase in the liver: regulation and functions

机译:肝脏中可诱导的一氧化氮合酶:调节和功能

获取原文
获取原文并翻译 | 示例
           

摘要

The inducible nitric oxide synthase (iNOS) gene is expressed by hepatocytes in a number of physiologic and pathophysiologic conditions affecting the liver including septic and hemorrhagic shock, The molecular regulation of iNOS expression is complex and occurs at multiple levels in the gene expression pathway: The cytokines TNF-#alpha#, ILl-#beta# and INF-#gamma# synergistically activate iNOS expression in the liver, and the human iNOS gene was first cloned from cytokine-stimulated hepatocytes, iNOS expression requires the transcription factor NF #kappa#B and is down-regulated by steriods, TGF-#beta#, the heat shock response, p53, and nitric oxide (NO) itself. In vivo, hepatic iNOS induction is differentially regulated from the typical acute-phase reactants and is not expressed as a mandatory component of the acute phase response. Thus, numerous mechanisms have evolved to regulate iNOS expression during hepatocellular injury. Studies of the effects.of NO, in the liver, demonstrate that induced NO synthesis plays an important role in hepatocyte function and protects the liver during sepsis and ischemia repefusion. Its cytoprotective role is best exemplified in a rodent model of endotoxemia. Here the addition of the non-specific NOS inhibitors significantly increased hepatic damage. NO exerts a protective effect through its ability to prevent intravascular thrombosis by inhibiting platelet adhesion and neutralizing toxic oxygen radicals. NO also exerts aprotective effects both in vivo and in vitro by blocking TNF-#alpha#-induced apoptosis and hepatotoxicity, in part by a thioldependent inhibition of caspase-3-1ike protease activity. These studies demonstrate the cytoprotective effects of NO in the liver and suggest that hepatic iNOS expression functions as an adaptive response to minimize inflammatory injury. In addition, NO has anti-tumor effects as well as known mutagenic effects, is involved in the systemic vasodilatation of cirrhosis, and has potent antimicrobial properties.
机译:诱导型一氧化氮合酶(iNOS)基因由肝细胞在许多影响肝脏的生理和病理生理条件下表达,包括败血性和失血性休克.iNOS表达的分子调控是复杂的,并且在基因表达途径中发生在多个层面:细胞因子TNF-#alpha#,IL1-#beta#和INF-#gamma#协同激活肝脏中的iNOS表达,并且人类iNOS基因首先从细胞因子刺激的肝细胞中克隆,iNOS表达需要转录因子NF#kappa# B,并受立体异构体,TGF-βbeta#,热激反应,p53和一氧化氮(NO)本身下调。在体内,肝脏iNOS的诱导与典型的急性期反应物有不同的调节作用,并且不表示为急性期反应的必需成分。因此,已经发展出许多机制来调节肝细胞损伤期间的iNOS表达。对肝脏中一氧化氮作用的研究表明,诱导的一氧化氮合成在败血症和缺血再灌注过程中在肝细胞功能中起着重要作用,并保护肝脏。它的细胞保护作用在内毒素血症的啮齿动物模型中得到最好的体现。在这里,添加非特异性NOS抑制剂可显着增加肝损伤。 NO通过抑制血小板粘附并中和有毒的氧自由基来预防血管内血栓形成,从而发挥保护作用。 NO还可以通过阻断TNF-α-诱导的细胞凋亡和肝毒性,在体内和体外发挥保护作用,部分是通过巯基依赖性抑制caspase-3-1ike蛋白酶的活性。这些研究证明了NO在肝脏中的细胞保护作用,并表明肝脏iNOS的表达可作为一种适应性反应,将炎症损伤降至最低。另外,NO具有抗肿瘤作用以及已知的诱变作用,参与肝硬化的全身血管舒张,并具有有效的抗微生物特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号